A new quadripolar cardiac resynchronization therapy pacemaker (CRT-P) was introduced recently. The devices have showcased tremendous promise in mitigating cardiovascular irregularities and preventing cardiac failure. As these devices get approval from healthcare organisations, the demand for cardiac resynchronization therapy is poised to increase proportionately. The cumulative force of...

The global Implantable Cardiac Rhythm Management (ICRM) Devices Market was valued at USD 15.87 billion in 2022 and is projected to reach USD 22.98 billion by 2032, with a rapid revenue CAGR of 4.2% during the forecast period. The market growth is primarily attributed to the increasing prevalence of Cardiovascular Diseases (CVDs) worldwide and the expanding geriatric population. Additionally,...